Home > > > > > Report Detail

Necrobiosis Lipoidica - Pipeline Insight, 2021

Publisher Name :
Date: 10-Feb-2021
No. of pages: 60
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Necrobiosis Lipoidica - Pipeline Insight, 2021," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Necrobiosis Lipoidica pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Geography Covered

- Global coverage

Necrobiosis Lipoidica Understanding

Necrobiosis Lipoidica: Overview

Necrobiosis lipoidica is a rare granulomatous skin disorder that usually appears in the shin area of the body and is often related to diabetes mellitus. It is an idiopathic dermatological condition. In the beginning, the lesions appear as erythematous circle papules that then evolve to well-demarcated, atrophic, shiny, yellow-brown telangiectasic multiple and bilateral plaques. The plaques develop slowly and rarely the condition ulcerates and become painful. The disease is more prevalent in females as compared to males. The exact cause of necrobiosis lipoidica is still unclear.

"Necrobiosis Lipoidica - Pipeline Insight, 2021" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Necrobiosis Lipoidica pipeline landscape is provided which includes the disease overview and Necrobiosis Lipoidica treatment guidelines. The assessment part of the report embraces, in depth Necrobiosis Lipoidica commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Necrobiosis Lipoidica collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Report Highlights

- The companies and academics are working to assess challenges and seek opportunities that could influence Necrobiosis Lipoidica R&D. The therapies under development are focused on novel approaches to treat/improve Necrobiosis Lipoidica.

Necrobiosis Lipoidica Emerging Drugs Chapters

This segment of the Necrobiosis Lipoidica report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Necrobiosis Lipoidica Emerging Drugs

- Secukinumab: Novartis

Novartis' lead drug candidate, Secukinumab is currently being evaluated for the treatment of necrobiosis lipoidica. The drug has demonstrated good efficacy in its phase I trial. It is a human IgG1 monoclonal antibody that selectively binds to the interleukin-17A (IL-17A) cytokine and inhibits its interaction with the IL-17 receptor thus, inhibiting the release of pro-inflammatory cytokines and chemokines.

Further product details are provided in the report……..

Necrobiosis Lipoidica: Therapeutic Assessment

This segment of the report provides insights about the different Necrobiosis Lipoidica drugs segregated based on following parameters that define the scope of the report, such as:

- Major Players in Necrobiosis Lipoidica

There are approx. 5+ key companies which are developing the therapies for Necrobiosis Lipoidica. The companies which have their Necrobiosis Lipoidica drug candidates in the most advanced stage, i.e. phase II include, Novartis.

- Phases

DelveInsight's report covers around 5+ products under different phases of clinical development like

- Late stage products (Phase III)

- Mid-stage products (Phase II)

- Early-stage product (Phase I) along with the details of

- Pre-clinical and Discovery stage candidates

- Discontinued & Inactive candidates

- Route of Administration

Necrobiosis Lipoidica pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

- Subcutaneous

- Intravenous

- Oral

- Intramuscular

- Molecule Type

Products have been categorized under various Molecule types such as

- Monoclonal Antibody

- Peptides

- Polymer

- Small molecule

- Product Type

Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Necrobiosis Lipoidica: Pipeline Development Activities

The report provides insights into different therapeutic candidates in phase II, I, preclinical and discovery stage. It also analyses Necrobiosis Lipoidica therapeutic drugs key players involved in developing key drugs.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Necrobiosis Lipoidica drugs.

Necrobiosis Lipoidica Report Insights

- Necrobiosis Lipoidica Pipeline Analysis

- Therapeutic Assessment

- Unmet Needs

- Impact of Drugs

Necrobiosis Lipoidica Report Assessment

- Pipeline Product Profiles

- Therapeutic Assessment

- Pipeline Assessment

- Inactive drugs assessment

- Unmet Needs

Key Questions

Current Treatment Scenario and Emerging Therapies:

- How many companies are developing Necrobiosis Lipoidica drugs?

- How many Necrobiosis Lipoidica drugs are developed by each company?

- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Necrobiosis Lipoidica?

- What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Necrobiosis Lipoidica therapeutics?

- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?

- What are the clinical studies going on for Necrobiosis Lipoidica and their status?

- What are the key designations that have been granted to the emerging drugs?

Key Players

- Novartis

- Processa Pharmaceuticals

Key Products

- Secukinumab

- PCS 499

Necrobiosis Lipoidica - Pipeline Insight, 2021

Table of Contents

Introduction
Executive Summary
Necrobiosis Lipoidica: Overview
* Causes
* Mechanism of Action
* Signs and Symptoms
* Diagnosis
* Disease Management
Pipeline Therapeutics
* Comparative Analysis
Therapeutic Assessment
* Assessment by Product Type
* Assessment by Stage and Product Type
* Assessment by Route of Administration
* Assessment by Stage and Route of Administration
* Assessment by Molecule Type
* Assessment by Stage and Molecule Type
Necrobiosis Lipoidica - DelveInsight's Analytical Perspective
In-depth Commercial Assessment
* Necrobiosis Lipoidica companies' collaborations, Licensing, Acquisition -Deal Value Trends
Necrobiosis Lipoidica Collaboration Deals
* Company-Company Collaborations (Licensing / Partnering) Analysis
* Company-University Collaborations (Licensing / Partnering) Analysis
Mid Stage Products (Phase II)
* Comparative Analysis
Secukinumab: Novartis
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
* Comparative Analysis
Drug Name: Company Name
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
* Comparative Analysis
Necrobiosis Lipoidica Key Companies
Necrobiosis Lipoidica Key Products
Necrobiosis Lipoidica- Unmet Needs
Necrobiosis Lipoidica- Market Drivers and Barriers
Necrobiosis Lipoidica- Future Perspectives and Conclusion
Necrobiosis Lipoidica Analyst Views
Necrobiosis Lipoidica Key Companies
Appendix

List of Tables

Table 1 Total Products for Necrobiosis Lipoidica
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products

List of Figures

Figure 1 Total Products for Necrobiosis Lipoidica
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products
  • Global Hyaluronic Acid Dermal Filler Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 88
    Hyaluronic Acid Dermal Filler are The product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, and adding facial volume and contour. The global Hyaluronic Acid Dermal Filler market was valued at US$ 2682.8 million in 2023 and is anticipated to reach US$ 5035.7 million by 2030, witnessing a CAGR of 9.3% during The forecast period 2024-2030. The producers mainly located in Europe, United States, China and Korea, such as Allergan,......
  • Global Hyaluronic Acid Based Dermal Fillers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Hyaluronic Acid Based Dermal Fillers market size was valued at US$ 2195.2 million in 2023. With growing demand in downstream market, the Hyaluronic Acid Based Dermal Fillers is forecast to a readjusted size of US$ 3708.9 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Hyaluronic Acid Based Dermal Fillers market. Hyaluronic Acid Based Dermal Fillers ar......
  • Global Dermal Fillers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Dermal Fillers market size was valued at US$ 5342.2 million in 2023. With growing demand in downstream market, the Dermal Fillers is forecast to a readjusted size of US$ 15850 million by 2030 with a CAGR of 16.8% during review period. The research report highlights the growth potential of the global Dermal Fillers market. Dermal Fillers are expected to show stable growth in the future market. However, product differentiation,......
  • Global Hyaluronic Acid Dermal Filler Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Hyaluronic Acid Dermal Filler market size was valued at US$ 2624.4 million in 2023. With growing demand in downstream market, the Hyaluronic Acid Dermal Filler is forecast to a readjusted size of US$ 5000.7 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Hyaluronic Acid Dermal Filler market. Hyaluronic Acid Dermal Filler are expected to show stable gr......
  • Global Pressure Ulcer Treatment Products Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Pressure Ulcer Treatment Products market size was valued at US$ 2150.3 million in 2023. With growing demand in downstream market, the Pressure Ulcer Treatment Products is forecast to a readjusted size of US$ 3021.5 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Pressure Ulcer Treatment Products market. Pressure Ulcer Treatment Products are expected t......
  • Global Dermatology Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Dermatology Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Dermatology Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Dermatology Drug market. Dermatology Drug are expected to show stable growth in the future market. However, product differentiation, reducing ......
  • Global Pruritus Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Pruritus Therapeutics market size was valued at US$ 13380 million in 2023. With growing demand in downstream market, the Pruritus Therapeutics is forecast to a readjusted size of US$ 17790 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Pruritus Therapeutics market. Pruritus Therapeutics are expected to show stable growth in the future market. However......
  • Global Scar Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Scar Treatment market size was valued at US$ 956.9 million in 2023. With growing demand in downstream market, the Scar Treatment is forecast to a readjusted size of US$ 1584.4 million by 2030 with a CAGR of 7.5% during review period. The research report highlights the growth potential of the global Scar Treatment market. Scar Treatment are expected to show stable growth in the future market. However, product differentiation, ......
  • Global Botox Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Botox market size was valued at US$ 4597.8 million in 2023. With growing demand in downstream market, the Botox is forecast to a readjusted size of US$ 9055 million by 2030 with a CAGR of 10.2% during review period. The research report highlights the growth potential of the global Botox market. Botox are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain opt......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs